Canagliflozin Reduces the Risk of Kidney Failure in Patients with Type 2 Diabetes Mellitus and Nephropathy: The CREDENCE Randomized Trial

Canagliflozin Reduces the Risk of Kidney Failure in Patients with Type 2 Diabetes Mellitus and Nephropathy: The CREDENCE Randomized Trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of general internal medicine : JGIM 2021-02
Hauptverfasser: Halalau, Alexandra, Fuller, William, Wheeler, Stephanie
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Journal of general internal medicine : JGIM
container_volume
creator Halalau, Alexandra
Fuller, William
Wheeler, Stephanie
description
doi_str_mv 10.1007/s11606-020-06216-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2487156649</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2487156649</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-4255cffdfdfc7b0ed69bc8a6d5759faa9c7fbde46876fa1b82bdf8f4211953a53</originalsourceid><addsrcrecordid>eNo9kc1u1DAUha2Kig6FF-ii8pJNwHb8F3YonRZEf9BoWFtOfN1xm0nS2FE18wa8NYYp1V3cxT3n6Op8CJ1R8okSoj5HSiWRBWGkIJJRWeyP0IIKJgrKK_UGLYjWvNCq5CfoXYwPhNCSMf0WnZSl4ErIaoF-17a3913w3bAPPV6Bm1uIOG0Ar0J8xIPHP4LrYYcvbejmCXBW_bQpQJ8ifg5pg9e7ETDDF8E2kLL3BroupDli2zt8C-NmGkabNrsveJ1T69XyYnlbL_Eqn4dt2IPD6ynY7j069raL8OFln6Jfl8t1_a24vrv6Xn-9LlpW6VRwJkTrvcvTqoaAk1XTaiudUKLy1lat8o0DLrWS3tJGs8Z57TmjtBKlFeUp-njIHafhaYaYzDbENv9sexjmaBjXigopeZWl7CBtpyHGCbwZp7C1085QYv4iMAcEJiMw_xCYfTadv-TPzRbcq-V_5-UfkzyDrA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2487156649</pqid></control><display><type>article</type><title>Canagliflozin Reduces the Risk of Kidney Failure in Patients with Type 2 Diabetes Mellitus and Nephropathy: The CREDENCE Randomized Trial</title><source>SpringerNature Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Halalau, Alexandra ; Fuller, William ; Wheeler, Stephanie</creator><creatorcontrib>Halalau, Alexandra ; Fuller, William ; Wheeler, Stephanie</creatorcontrib><identifier>ISSN: 0884-8734</identifier><identifier>EISSN: 1525-1497</identifier><identifier>DOI: 10.1007/s11606-020-06216-z</identifier><identifier>PMID: 33547569</identifier><language>eng</language><publisher>United States</publisher><ispartof>Journal of general internal medicine : JGIM, 2021-02</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-4255cffdfdfc7b0ed69bc8a6d5759faa9c7fbde46876fa1b82bdf8f4211953a53</cites><orcidid>0000-0002-1805-992X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33547569$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Halalau, Alexandra</creatorcontrib><creatorcontrib>Fuller, William</creatorcontrib><creatorcontrib>Wheeler, Stephanie</creatorcontrib><title>Canagliflozin Reduces the Risk of Kidney Failure in Patients with Type 2 Diabetes Mellitus and Nephropathy: The CREDENCE Randomized Trial</title><title>Journal of general internal medicine : JGIM</title><addtitle>J Gen Intern Med</addtitle><issn>0884-8734</issn><issn>1525-1497</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNo9kc1u1DAUha2Kig6FF-ii8pJNwHb8F3YonRZEf9BoWFtOfN1xm0nS2FE18wa8NYYp1V3cxT3n6Op8CJ1R8okSoj5HSiWRBWGkIJJRWeyP0IIKJgrKK_UGLYjWvNCq5CfoXYwPhNCSMf0WnZSl4ErIaoF-17a3913w3bAPPV6Bm1uIOG0Ar0J8xIPHP4LrYYcvbejmCXBW_bQpQJ8ifg5pg9e7ETDDF8E2kLL3BroupDli2zt8C-NmGkabNrsveJ1T69XyYnlbL_Eqn4dt2IPD6ynY7j069raL8OFln6Jfl8t1_a24vrv6Xn-9LlpW6VRwJkTrvcvTqoaAk1XTaiudUKLy1lat8o0DLrWS3tJGs8Z57TmjtBKlFeUp-njIHafhaYaYzDbENv9sexjmaBjXigopeZWl7CBtpyHGCbwZp7C1085QYv4iMAcEJiMw_xCYfTadv-TPzRbcq-V_5-UfkzyDrA</recordid><startdate>20210205</startdate><enddate>20210205</enddate><creator>Halalau, Alexandra</creator><creator>Fuller, William</creator><creator>Wheeler, Stephanie</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1805-992X</orcidid></search><sort><creationdate>20210205</creationdate><title>Canagliflozin Reduces the Risk of Kidney Failure in Patients with Type 2 Diabetes Mellitus and Nephropathy: The CREDENCE Randomized Trial</title><author>Halalau, Alexandra ; Fuller, William ; Wheeler, Stephanie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-4255cffdfdfc7b0ed69bc8a6d5759faa9c7fbde46876fa1b82bdf8f4211953a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Halalau, Alexandra</creatorcontrib><creatorcontrib>Fuller, William</creatorcontrib><creatorcontrib>Wheeler, Stephanie</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of general internal medicine : JGIM</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Halalau, Alexandra</au><au>Fuller, William</au><au>Wheeler, Stephanie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Canagliflozin Reduces the Risk of Kidney Failure in Patients with Type 2 Diabetes Mellitus and Nephropathy: The CREDENCE Randomized Trial</atitle><jtitle>Journal of general internal medicine : JGIM</jtitle><addtitle>J Gen Intern Med</addtitle><date>2021-02-05</date><risdate>2021</risdate><issn>0884-8734</issn><eissn>1525-1497</eissn><cop>United States</cop><pmid>33547569</pmid><doi>10.1007/s11606-020-06216-z</doi><orcidid>https://orcid.org/0000-0002-1805-992X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0884-8734
ispartof Journal of general internal medicine : JGIM, 2021-02
issn 0884-8734
1525-1497
language eng
recordid cdi_proquest_miscellaneous_2487156649
source SpringerNature Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
title Canagliflozin Reduces the Risk of Kidney Failure in Patients with Type 2 Diabetes Mellitus and Nephropathy: The CREDENCE Randomized Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A25%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Canagliflozin%20Reduces%20the%20Risk%20of%20Kidney%20Failure%20in%20Patients%20with%20Type%202%20Diabetes%20Mellitus%20and%20Nephropathy:%20The%20CREDENCE%20Randomized%20Trial&rft.jtitle=Journal%20of%20general%20internal%20medicine%20:%20JGIM&rft.au=Halalau,%20Alexandra&rft.date=2021-02-05&rft.issn=0884-8734&rft.eissn=1525-1497&rft_id=info:doi/10.1007/s11606-020-06216-z&rft_dat=%3Cproquest_cross%3E2487156649%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2487156649&rft_id=info:pmid/33547569&rfr_iscdi=true